Abstract
A total of four children with osteogenesis imperfecta, three with type I and one with type III forms of the disease, were treated with synthetic salmon calcitonin for 18-24 months. The annual fracture rate was decreased during calcitonin therapy compared with the period preceding it. No patient presented a marked inflexion in linear growth and a transient improvement was even noticed in two cases.
| Original language | English |
|---|---|
| Pages (from-to) | 401-5 |
| Number of pages | 5 |
| Journal | Journal of molecular medicine (Berlin, Germany) |
| Volume | 17 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Jul 1989 |
Keywords
- Age Determination by Skeleton
- Body Height
- Bone Development
- Calcitonin
- Child
- Child, Preschool
- Female
- Fractures, Bone
- Humans
- Male
- Osteogenesis Imperfecta
- Journal Article
Fingerprint Dive into the research topics of 'Effects of synthetic salmon calcitonin therapy in children with osteogenesis imperfecta'. Together they form a unique fingerprint.
Cite this
Rebelo, I., Pereira-da-Silva, L., Blanco, J. C., Monteiro, M. E., & Ferreira, N. C. (1989). Effects of synthetic salmon calcitonin therapy in children with osteogenesis imperfecta. Journal of molecular medicine (Berlin, Germany), 17(4), 401-5. https://doi.org/10.1177/030006058901700415